Author
Number of items: 3.
2019
  • Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal
  • Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal
    • 2018
  • Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency. (2018) Mir-Saeed Shayegan Salek, Tatyana Ionova, Jeffrey Johns and Esther Natalie Oliva